EFFECTS OF DOSE, PH AND OSMOLARITY ON INTRANASAL ABSORPTION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN RATS

被引:0
|
作者
SHIMODA, N [1 ]
MAITANI, Y [1 ]
MACHIDA, Y [1 ]
NAGAI, T [1 ]
机构
[1] CHUGAI PHARMACEUT CO LTD, DEPT BUSINESS COORDINAT, DIV DEV & TECHNOL, KITA KU, TOKYO 115, JAPAN
关键词
ERYTHROPOIETIN; INTRANASAL ADMINISTRATION; GLYCOPROTEIN CIRCULATING RETICULOCYTE; BIOAVAILABILITY;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of dose, pH and osmolarity on the intranasal absorption of a recombinant human erythropoietin (rEPO) solution were studied in male Wistar rats, The intranasal administration of rEPO was evaluated by measuring percentage circulating reticulocytes of red blood cells on a stained blood smear (smear method), and also by measuring residual circulating reticulocyte counts using a microcell counter (sysmex method), Both results suggest that rEPO solution was absorbed through the nasal mucosa of rats without enhancers after a single intranasal administration, The pharmacological availabilities of rEPO after intranasal administration compared with intravenous administration were about 7% and 4%, when estimated by smear method and sysmex method, respectively, The pharmacological activity was enhanced in low pH and hypotonic mannitol solution.
引用
收藏
页码:734 / 739
页数:6
相关论文
共 50 条
  • [1] COMPARATIVE PHARMACOKINETICS AND DISTRIBUTION OF HUMAN URINARY ERYTHROPOIETIN AND RECOMBINANT-HUMAN-ERYTHROPOIETIN IN RATS
    KINOSHITA, H
    OHISHI, N
    KATO, M
    TOKURA, S
    OKAZAKI, A
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1991, 41-2 (09): : 1004 - 1007
  • [2] DOSE-DEPENDENT EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON THE RETICULOCYTE POPULATION OF RABBITS
    FUCHS, A
    EDER, H
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1992, 42-2 (10): : 1266 - 1268
  • [3] THE TREATMENT OF ANEMIA WITH LOW-DOSE RECOMBINANT-HUMAN-ERYTHROPOIETIN
    ARONOFF, GR
    DUFF, DR
    SLOAN, RS
    BRIER, ME
    MAURICE, B
    ERICKSON, B
    GOLPER, TA
    AMERICAN JOURNAL OF NEPHROLOGY, 1990, 10 : 40 - 43
  • [4] THE ADVERSE-EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY
    WONG, KC
    LI, PKT
    LUI, SF
    NICHOLLS, MG
    LAI, KN
    ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS, 1990, 9 (04) : 183 - 206
  • [5] THE USES OF RECOMBINANT-HUMAN-ERYTHROPOIETIN
    PATTERSON, KG
    SAUDI MEDICAL JOURNAL, 1994, 15 (01) : 1 - 13
  • [6] PHARMACOKINETICS AND DISTRIBUTION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN RATS WITH RENAL DYSFUNCTION
    KINOSHITA, H
    OHISHI, N
    TOKURA, S
    OKAZAKI, A
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1992, 42-1 (05): : 682 - 686
  • [8] INTRAPERITONEAL ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN
    FRENKEN, LAM
    STRUIJK, DG
    COPPENS, PJW
    TIGGELER, RGWL
    KREDIET, RT
    KOENE, RAP
    PERITONEAL DIALYSIS INTERNATIONAL, 1992, 12 (04): : 378 - 383
  • [9] EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHEPO) ON MYELOPOIESIS AND THROMBOPOIESIS OF RABBITS
    FUCHS, A
    EDER, H
    COMPARATIVE HAEMATOLOGY INTERNATIONAL, 1992, 2 (04): : 186 - 189
  • [10] DISTRIBUTION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN FOLLOWING MULTIPLE INTRAVENOUS ADMINISTRATION AND EFFECTS OF AGE ON THE DISTRIBUTION IN RATS
    KINOSHITA, H
    OHISHI, N
    KATO, M
    TOKURA, S
    OKAZAKI, A
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1992, 42-1 (04): : 579 - 584